Jounce Therapeu CVR Contra Cus
13F holders, Q4 2024 (December 31)3holders +1
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Jounce Therapeu CVR Contra Cus in their 13F filings, up 1 from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Moloney Securities Asset Management, LLC ($0), Erste Asset Management GmbH ($0) and Crowley Wealth Management, Inc. ($0).
- Company
- Jounce Therapeu CVR Contra Cus
- Filed as
- CONTRA JOUNCE THERAPEUTI (Q4 2024)
- CUSIP
- 481CVR017
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Moloney Securities Asset Management, LLC | 0.00% | No change | 176,450 | $0 |
| Erste Asset Management GmbH | 0.00% | No change | 1,559,587 | $0 |
| Crowley Wealth Management, Inc. | 0.00% | — | 1,300 | $0 |
"% of holder's portfolio" is JOUNCE THERAPEU CVR CONTRA CUS's weight in each manager's 13F, not the share of Jounce Therapeu CVR Contra Cus the manager owns.